12:00 AM
Dec 17, 2012
 |  BC Week In Review  |  Company News  |  Deals

Protalix, Pfizer deal

Protalix agreed to continue to conduct and sponsor ongoing clinical trials with Gaucher's disease drug Elelyso taliglucerase alfa, while Pfizer agreed to conduct and sponsor any new clinical trials with...

Read the full 136 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >